COMAX | FGJMX | COMAX / FGJMX | |
Total Expense Ratio | 1.25 | 0.71 | 176% |
Annual Report Gross Expense Ratio | 1.46 | 0.71 | 206% |
Fund Existence | 42 years | 7 years | - |
Gain YTD | -24.855 | 21.012 | -118% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 1000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 108M | 2.14B | 5% |
Annual Yield % from dividends | 0.00 | 0.00 | - |
Returns for 1 year | -14.20 | 34.67 | -41% |
Returns for 3 years | 20.65 | 100.16 | 21% |
Returns for 5 years | 0.87 | 84.90 | 1% |
Returns for 10 years | 30.30 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
QISCX | 28.47 | 0.18 | +0.64% |
Federated Hermes MDT Small Cap Core IS | |||
VALIX | 14.37 | 0.02 | +0.14% |
Value Line Capital Appreciation Investor | |||
FMILX | 66.22 | N/A | N/A |
Fidelity New Millennium | |||
PHPIX | 26.42 | -0.01 | -0.04% |
ProFunds Pharmaceuticals UltraSector Inv | |||
JNVIX | 19.09 | -0.03 | -0.16% |
Jensen Quality Mid Cap I |